Newsroom

Three years since our launch, we are taking innovative approaches and continuing to deliver results from both IMI and IHI projects.

Thera4Care brings together diverse stakeholders with the aim of establishing an integrated, collaborative European ecosystem for theranostics.

The new project plans to develop innovative synthetic data generation and sharing solutions for use in biomedical research.

The project aims to make it easier to detect if patients are likely to benefit from a novel treatment, and deliver improved manufacture methods to minimise the risk of shortages.

The new IHI project aims to address gaps along the whole stroke care pathway, from diagnosis and emergency treatment, to rehabilitation and the prevention of further strokes.

We publish the draft topics ahead of the call launch to give applicants extra time to start networking and preparing a proposal.

The report summarises the discussions and main takeaways of the IHI Regulatory Science Summit held earlier in 2024.

The new project aims to boost cancer care in Europe by advancing the development and manufacture of therapies and diagnostics based on the radioactive isotope astatine-211.

VICT3R will use existing data and artificial intelligence to create virtual control groups that could replace real animals in drug and chemical safety studies.

While previous IHI calls defined the challenges applicants should address, call 9 will invite applicants to identify untapped opportunities in the IHI Strategic Research and...

A wide-ranging evaluation of IMI2 and IHI highlights the ability of the programmes to drive innovation and have an impact on patient care and quality of life.

Ultimately, SYNTHIA hopes to build trust regarding the usefulness of synthetic data and facilitate its responsible use by researchers.

Hitting the 200 project milestone shows the strength of the public-private partnership approach pioneered by the Innovative Medicines Initiative and built on by IHI.

Health research collaborations mean sharing data – we can deliver faster if we identify and remove obstacles early, write IHI's Niklas Blomberg and EFPIA's Magda Chlebus.

By placing patients at the centre of the system, IMPROVE should advance the use of patient-generated data in treatment decisions and research.

New to IHI and want to see what we’re all about? Our new brochure, IHI 2023 In Focus, outlines our main achievements in 2023.

IHI call 8 features topics on heart disease in cities, big data and arthritis, ‘regulatory sandboxes’, and how best to measure the impacts of a therapy on patients’ lives.

We publish the draft topics ahead of the call launch to give applicants extra time to start preparing a proposal and building a consortium.

The new IHI project’s state-of-the-art platform will help to advance research by driving innovative, real-world data collection from patients with rare neuromuscular diseases.

We publish the draft topics ahead of the call launch to give applicants extra time to start networking and preparing a proposal.

The new IHI project plans to set up a platform to identify people in the early stages of liver disease, when damage to the liver can be halted and even reversed.

The GRIPonMASH project aims to transform the way we detect and diagnose a common, but little-known, liver condition dubbed MASLD.

The new IHI project aims to boost the use of non-invasive CT scans in the diagnosis and care of people with coronary artery disease.

Read our guide to find out how to maximise the regulatory impact of an IHI/IMI project.

IHI’s Regulatory Science Summit provided a forum to discuss how IHI projects can help overcome current regulatory challenges and contribute to regulatory science

The new IHI project hopes its ‘toolbox platform’ will dramatically change the way we detect, diagnose, prevent and treat Alzheimer’s disease.

The papers in Frontiers in Neurology demonstrate how public-private collaborative research through IMI and now IHI is making a difference in the Alzheimer’s disease field.

The new IHI project aims to make intensive care units more peaceful for staff and patients alike by using smart technologies to cut the number of alarms.

The new IHI project wants to identify people at risk of dementia, before the first symptoms appear, when there is still time to take steps to slow the progress of the disease.

HEU-EFS aims to develop a harmonised approach to early feasibility studies (EFS) for medical devices in the EU, a key step in the early development of new devices.

For the International Day of Women and Girls In Science, we spoke to some of the women working with IHI and IMI to hear how funding organisations can help women to thrive.

New IHI project EDENT1FI aims to improve our ability to detect type 1 diabetes in children and adolescents before the body’s insulin-producing cells have been badly damaged.

iCARE4CVD aims to facilitate a more personalised approach to cardiovascular disease care, from identifying those at risk right through to caring for people with advanced disease.

Niklas Blomberg, our new Executive Director, shares his story with us.

The Innovative Health Initiative (IHI) has launched two new calls for proposals, IHI calls 6 and 7, addressing a wide range of challenges in health research and innovation.

The final versions of the topic texts for IHI calls 6 and 7 are available now; the calls will be launched in the next few days

The IHI Programme Office will be closed from 23 December 2023 to 2 January 2024 inclusive.

With the launch of the first IHI projects, the vision of a cross-sector, public-private research and innovation community is turning into a reality.

Updated versions of the draft topics for IHI calls 6 and 7 are available now on the Future Opportunities page. We hope to launch the calls early next year.

If you have an idea for IHI’s future research, we’d love to hear from you! Discover our Ideas Incubator and inspire health innovation at IHI.

The draft texts of the topics slated for inclusion in IHI’s next calls for proposals are now available online.

CLAIMS will develop an AI-based platform for multiple sclerosis patients that would help to predict the course of the disease and identify the best treatments for them.

Following surgery to remove a tumour, blood tests could help to identify which patients really need further treatment, and which don’t.

IMAGIO focuses on ‘interventional oncology’, which uses miniaturised instruments to target cancer cells more precisely, thereby sparing health cells.

The topics contribute to key EU policies such as the European Green Deal and the '3Rs' goals of replacing, reducing and refining the use of animals in research.

The project aims to set up a digital platform to improve the diagnosis and personalised treatment of people with Alzheimer’s plus other diseases.

The topics cover subjects as diverse as cutting animal testing in research, sustainability in healthcare, rare diseases, and equitable access to clinical research.

The 120 members of the pool include both patients and caregivers and have experience of a wide range of health issues.

IDERHA will create an open health data platform that will facilitate the integration and analysis of diverse types of data, and use it to transform lung cancer diagnosis and care.

Dr Blomberg has worked in both research and leadership roles in Europe's life sciences sector, and is currently Director of ELIXIR, the life sciences data infrastructure.

Addressing cancer and neurodegenerative diseases, and bringing on board sectors as diverse as pharmaceuticals, medical technology, big data and imaging, the projects exemplify IHI...

The topics cover subjects as diverse as sustainability in healthcare, rare diseases, and equitable access to clinical research. Registration for the IHI Call Days is also open.

IHI is calling on patients and informal caregivers to apply to be part of a new IHI Patient Pool which will strengthen IHI’s ties with the patient community, and make it easier to...

The two organisations have signed a Memorandum of Understanding that will facilitate collaboration and allow them to leverage their strengths, networks and expertise.

The Innovative Health Initiative (IHI) has launched its third call for proposals, featuring topics covering rare diseases and mental health, and addressing challenges such as...

As we mark the Innovative Health Initiative’s first birthday on 30 November, we look back on what we have achieved so far, and offer a glimpse of our plans for the coming year.

Updated versions of the draft topics for IHI calls 3 and 4 have been published on the Future Opportunities page.

The Science Innovation Panel (SIP) is a new body set up under IHI to advise the Governing Board on a range of matters. In an interview with the IHI Programme Office, chair Anna...

The short brochure describes recent IMI project results in fields such as cancer, antimicrobial resistance, COVID-19 and more.

Digital technologies in mental health care, advanced therapies for rare diseases, and improving hospital care are among the topics pencilled in for IHI’s next calls for proposals.

Dr Hugh Laverty has taken over as interim Executive Director at the Innovative Health Initiative (IHI), following the departure of Dr Pierre Meulien.

As Pierre Meulien completes his 7-year term as Executive Director of IHI, he reflects on how the research and innovation process has changed and will continue to undergo rapid...

Through the States Representatives Group (SRG), Member States provide vital input into the direction of IHI, as SRG chair Martha Cahill explains in this interview.

The joint undertakings are about creating public-private partnerships (PPPs) – and IHI is no exception. In an interview, the European Commission’s Irene Norstedt, chair of the...

The Innovative Health Initiative (IHI) has launched its first calls for proposals, with topics on diseases such as cancer, cardiovascular disease and neurodegenerative diseases, as...

Cancer, heart disease and neurodegenerative diseases as well as health data and early feasibility studies are the focus of IHI’s first calls for proposals, which are due to be...

The newly appointed members of the Innovative Health Initiative Science and Innovation Panel have a wealth of scientific expertise and extensive experience of diverse aspects of...

IHI seeks an ‘outstanding and dynamic professional’ with top leadership, scientific and people skills to take on the role of Executive Director of the public-private partnership...

The IHI Governing Board has formally approved the Strategic Research and Innovation Agenda (SRIA), which will guide IHI’s scientific priorities in the years to come.

The Innovative Health Initiative (IHI) is looking for people who want to represent the scientific and wider healthcare communities in its new Science and Innovation Panel (SIP)...

Cancer, heart disease and neurodegenerative diseases are among the themes that could be included in the first calls for proposals launched under the new Innovative Health...

The eight members of the Governing Board represent the Innovative Health Initiative (IHI) public and private partners. The chair of the newly-created board is Irene Norstedt of the...

We welcome entry into force of the legislation creating the Innovative Health Initiative (IHI), a new European partnership for health under Horizon Europe.

The Innovative Medicines Initiative (IMI) organically grew into a powerhouse of international alliances. The new partnership’s multi-sectoral nature means that the catchment will...